PANCREAS ADENOCARCINOMA
Clinical trials for PANCREAS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREAS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREAS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Pancreatic cancer drug combo trial halted early
Disease control TerminatedThis early-phase study tested a drug called CPI-613 (Devimistat) combined with chemotherapy and radiation for people with pancreatic cancer that cannot be removed by surgery. The goal was to find the safest dose and see if the combination helps control the disease. Only 8 people …
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Liquid biopsy study halted early – but data may still inform cancer care
Knowledge-focused TerminatedThis study looked at whether a blood test (liquid biopsy) could help doctors make better treatment decisions for people with advanced cancers of the colon, pancreas, or bile duct. The goal was to see if the test results would change how the cancer was managed. The study was stopp…
Matched conditions: PANCREAS ADENOCARCINOMA
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC